Pharmacotherapy for depression in diabetics;Pharmakotherapie der Depression bei Menschen mit Diabetes

Diabetologe

Volumn 6, Issue 4, 2010, Pages 280-286

  Kahl, K G ^a   Lampen Inkamp, S ^a   Gollner K ^a   Liersch, J ^a   Claassen, B ^a   Wilkening, A ^a   Schik, G ^a   Peschel, T ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Antidepressants; Depression; Sexual dysfunction; Type 2 diabetes; Weight

Indexed keywords

ANTIDEPRESSANT AGENT;

COMORBIDITY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; HUMAN; INTERVENTION STUDY; LIFESTYLE; MAJOR DEPRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; PSYCHOEDUCATION; PSYCHOTHERAPY; REVIEW; SCREENING;

EID: 77956342476     PISSN: 18609716     EISSN: 18609724     Source Type: Journal    
DOI: 10.1007/s11428-009-0534-6     Document Type: Review

References (32)

1. Mezuk B, Eaton WW, Albrecht S, Golden SH (2008) Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 31:2383-2390
2. Kahl KG (2005) The metabolic syndrome and mental illness: relevance, risk factors and practical consequences. MMW Fortschr Med 147:32-34, 36
3. Schweiger U, Greggersen W, Rudolf S et al (2008) Disturbed glucose disposal in patients with major depression; application of the glucose clamp technique. Psychosom Med 70:170-176
4. Kahl KG, Bester M, Greggersen W et al (2005) Visceral fat deposition and insulin sensitivity in depressed women with and without comorbid borderline personality disorder. Psychosom Med 67:407-412
5. Herrmann-Lingen C, Buss U, Snaith RP (2007) Hospital anxiety and depression scale: HADS-D; deutsche Version; ein Fragebogen zur Erfassung von Angst und Depressivität in der somatischen Medizin; Testdokumentation und Handanweisung. Huber, Bern
6. Dilling H, World Health Organization (2008) Internationale Klassifikation psychischer Störungen: ICD-10, Kapitel V (F); klinisch-diagnostische Leitlinien. Huber, Bern
7. Barbui C, Ostuzzi G, Cipriani A (2009) SSRI plus supportive care more effective than supportive care alone for mild to moderate depression. Evid Based Ment Health 12:109
8. Rush AJ, Fava M, Wisniewski SR et al (2004) Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. Control Clin Trials 25:119-142
9. Rush AJ (2007) STAR*D: what have we learned? Am J Psychiatry 164:201-204
10. Rush AJ, Trivedi MH, Wisniewski SR et al (2006) Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 163:1905-1917
11. Lustman PJ, Griffith LS, Freedland KE et al (1998) Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med 129:613-621
12. Williams JW Jr, Katon W, Lin EH et al (2004) The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann Intern Med 140:1015-1024
13. Katon WJ, Von Korff M, Lin EH et al (2004) The pathways study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry 61:1042-1049
14. Katon W, Unutzer J, Fan MY et al (2006) Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression. Diabetes Care 29:265-270
15. Cipriani A, Furukawa TA, Salanti G et al (2009) Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 373:746-758
16. Drieling T, Biedermann NC, Scharer LO et al (2007) Psychotropic drug-induced change of weight: a review. Fortschr Neurol Psychiatr 75:65-80
17. Dannon PN, Iancu I, Cohen A et al (2004) Three year naturalistic outcome study of panic disorder patients treated with paroxetine. BMC Psychiatry 4:16
18. Bouwer CD, Harvey BH (1996). Phasic craving for carbohydrate observed with citalopram. Int Clin Psychopharmacol 11:273-278
19. Lunn MP, Hughes RA, Wiffen PJ (2009) Duloxetine for treating painful neuropathy or chronic pain. Cochrane Database Syst Rev CD007115
20. Kadiroglu AK, Sit D, Kayabasi H et al (2008) The effect of venlafaxine HCl on painful peripheral diabetic neuropathy in patients with type 2 diabetes mellitus. J Diabetes Complications 22:241-245
21. Thase ME (1998) Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients. J Clin Psychiatry 59:502-508
22. Derby MA, Zhang L, Chappell JC et al (2007) The effects of supratherapeutic doses of duloxetine on blood pressure and pulse rate. J Cardiovasc Pharmacol 49:384-393
23. Montgomery SA (1995) Safety of mirtazapine: a review. Int Clin Psychopharmacol 10 (Suppl 4):37-45
24. Wade A, Crawford GM, Angus M et al (2003) A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care. Int Clin Psychopharmacol 18:133-141
25. Bakish D, Bradwejn J, Nair N et al (1992) A comparison of moclobemide, amitriptyline and placebo in depression: a Canadian multicentre study. Psychopharmacology (Berl) 106 (Suppl):S98-S101
26. Moll E, Neumann N, Schmid-Burgk W et al (1994) Safety and efficacy during long-term treatment with moclobemide. Clin Neuropharmacol 17 (Suppl 1):S74-S87
27. Remick RA, Froese C, Keller FD (1989) Common side effects associated with monoamine oxidase inhibitors. Prog Neuropsychopharmacol Biol Psychiatry 13:497-504
28. Croft H, Settle E Jr, Houser T et al (1999) A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline. Clin Ther 21:643-658
29. Kennedy SH, Rizvi S, Fulton K, Rasmussen J (2008) A double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR. J Clin Psychopharmacol 28:329-333
30. Ghosh A, Hellewell JS (2007) A review of the efficacy and tolerability of agomelatine in the treatment of major depression. Expert Opin Investig Drugs 16:1999-2004
31. De Hert M, Dekker JM, Wood D et al (2009) Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry 24:412-424
32. Benkert O, Hippius H (2009) Kompendium der psychiatrischen Pharmakotherapie: mit 60 Tabellen. Springer, Berlin Heidelberg New York